Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects-Reference-Cited by-同舟云学术

Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects

Published:2010-11-03 Issue:5 Volume:303 Page:317-325
ISSN:0340-3696
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Zinnamosca Laura,Petramala Luigi,Cotesta Dario,Marinelli Cristiano,Schina Mauro,Cianci Rosario,Giustini Sandra,Sciomer Susanna,Anastasi Emanuela,Calvieri Stefano,De Toma Giorgio,Letizia Claudio

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00403-010-1090-z.pdf

Reference35 articles.

1. Bausch B, Borozdin W, Mautner VF et al (2007) Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab 92(7):2784–2792

2. Bravo EL, Tagle R (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24:539–553

3. Ceruti M, Petramala L, Cotesta D et al (2006) Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases. J Clin Hypertens 8:642–648

4. Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104:593–604

5. Cotesta D, Erlic Z, Petramala L et al (2008) Coincidence of neurofibromatosis Type 1 and multiple endocrine neoplasia type 2. Endocrinologist 18:277–281

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory rhabdomyoblastic tumor, pheochromocytoma, and pulmonary hamartoma in a patient with neurofibromatosis type 1: a case report;Diagnostic Pathology;2024-06-11

2. Giant Cystic Pheochromocytoma Associated With Neurofibromatosis Type 1: A Case Report;Cureus;2024-05-12

3. Overview of endocrine tumor syndromes manifesting as adrenal tumors;The Ewha Medical Journal;2024-01-31

4. Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes;Molecular Genetics & Genomic Medicine;2023-12-22

5. NF1 alterations in cancers: therapeutic implications in precision medicine;Expert Opinion on Investigational Drugs;2023-10-03